Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures (0.21%), Hang Seng Futures +0.69%, ASX SPI 200 (0.16%), S&P Futures +0.05%

Sep 14 ,2026

  • Synopsis:

    • Asian markets set for mixed start to Tuesday trade. Futures signaling steep opening decline South Korea, milder initial loss in Japan. Hong Kong tracking for gains while ASX futures little changed. S&P 500 futures unchanged afterhours. Australian bonds weaker after Treasury yield curve bear flattened overnight. Crude came off earlier highs. Gold and silver remain lower. FX markets steady after dollar index rose to early September highs. Bitcoin fluctuating below $80K.

    • AI trade remained under pressure with SOX closing down 6% overnight following Anthropic's call to slow pace of model development. While Anthropic's call drew immediate concerns about potential supply chain impacts, there was also a healthy dose of skepticism a slowdown in model capability will translate to weaker capex. Industry calls for more regulation also invited pushback from White House and criticism from China.

    • China activity data forecast to show industrial production rose in August as weather impacts eased and AI-related demand continues to underpin high-tech manufacturing. Retail sales growth also forecast to have steadied though auto sales were down sharply in August. Fixed asset investment declines expected to have worsened amid ongoing property market slump. Comes after August lending data underwhelmed in a sign of weak household credit demand.

  • Pre-open Company News:

    • 2345.TT -- Accton Technology resumed outperform at KGI Securities

    • 2890.TT -- SinoPac Financial's existing shareholders can subscribe for 34.6 shares for every 1K shares held for company's capital raise

    • PNB.PM -- Philippine National Bank downgraded to hold from buy at COL Financial Group

    • BNTX -- BioNTech, OncoC4 present first OS data from stage 1 of PRESERVE-003 trial of gotistobart at WCLC

    • 300765.CH -- CSPC Innovation Pharmaceutical presents data from Phase I/II clinical study of SYS6010 in combination with enlonstobart at WCLC

    • 603885.CH -- Juneyao Airlines reports August traffic +6.26% y/y

    • 2882.TT -- Cathay Financial Holdings reports August net income NT$11.30B; StreetAccount notes the year-ago figure was NT$10.27B

    • 1798.HK -- China Datang Corp. Renewable Power reports August power generation 1,924 GWh, (9.8%) y/y

    • 2886.TT -- Mega Financial Holding reports August net income NT$3.56B; StreetAccount notes year-ago figure was NT$3.03B

    • 000089.CH -- Shenzhen Airport reports August passenger throughput 6.1M, +5.1% y/y

    • 3377.HK -- Sino-Ocean Group Holdings reports August contracted sales CNY0.75B; StreetAccount notes the year-ago figure was CNY1.70B

    • 9887.HK -- Nanjing Leads Biolabs presents updated data from phase II clinical study of LBL-024 combined with chemotherapy in NSCLC

    • 601958.CH -- Jinduicheng Molybdenum appoints He Xin as general manager, effective immediately

  • On Deck:

    • China:

      • Economic:

        • 08:00 CST: Foreign Direct Investment Y/Y; consensus

        • 10:00 CST: Industrial Output NSA Y/Y; consensus +4.9%

        • 10:00 CST: Retail Sales NSA Y/Y; consensus +0.7%

    • Hong Kong:

      • Earnings:

        • Trip.com Group (9961.HK)

    • Japan:

      • Economic:

        • 13:30 JST: Retail Sales NSA Y/Y (Final); consensus

      • Earnings:

        • ASKUL Corp (2678.JP)

  • Market Data:

    • Gold (Dec 26): ($22.00) or (0.51%) to $4329.90

    • WTI Crude (Oct 26): +$0.69 or +0.68% to $102.08

    • $-¥: +0.81 or +0.52% to 154.3850

    • $-KRW: +4.14 or +0.31% to 1345.6700

    • A$-$: (0.00) or (0.46%) to 0.7138

    • $-INR: +0.24 or +0.25% to 95.8354

    • $-CNY: +0.01 or +0.10% to 6.7148

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE